Evaluating the effectiveness of surgical guides for zygomatic implants
PRECISION OF SURGICAL GUIDES FOR PLACEMENT OF EXTRA-LARGE DENTAL IMPLANTS. A PILOT STUDY
This study is testing if using special guides for placing zygomatic implants is more accurate and causes less pain than the usual freehand method for patients aged 18-80.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Sex | All |
| Sponsor | Universidad Complutense de Madrid Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Madrid and 1 other locations) |
| Trial ID | NCT06737289 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the accuracy of guided surgical splints in the placement of zygomatic implants compared to traditional freehand techniques. It will involve patients aged 18-80 who consent to undergo preoperative and postoperative imaging. The study will analyze variations in implant placement accuracy based on implant length and location, as well as evaluate pain levels and surgical time associated with the guided technique. The use of advanced imaging software will facilitate precise comparisons of outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 who require zygomatic implants and meet specific health criteria.
Not a fit: Patients with a history of smoking, alcoholism, or recent oncological treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the safety and effectiveness of zygomatic implant procedures for patients.
How similar studies have performed: While the use of surgical guides is gaining traction, this study is among the first to directly compare guided and freehand techniques in zygomatic implant placement.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Age between 18-80 years of age, patients who sign the informed consent form and patients who consent to undergo preoperative and postoperative orthopantomography and CT scans. Exclusion Criteria: * Smoking (more than 10 cigarettes per day). * Alcoholism (more than 25g/day in women and more than 40g/day in men according to WHO criteria), * Oncological treatment (history of treatment in the last 6 months or current treatment with chemotherapy or radiotherapy). * History of head and neck radiotherapy. * Allergic to anesthetics or antibiotics.
Where this trial is running
Madrid and 1 other locations
- Jesus — Madrid, Spain (Recruiting)
- Ucm — Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: JEsus Torres, PhD — Ucm
- Study coordinator: Jesus Torres, PhD
- Email: jesus.torres@ucm.es
- Phone: 653050071
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.